OMG, That's what was afraid of. No wonder they released the financials at 6pm, so nobody would see them. You're probably the only to catch that.
But what bothers me also is that they speak of Alvio as their proprietary product. It's not.
They came out with a press release a long time ago, stating that they entered into an agreement with a company called Qol Devices to help them develop Alvio in exchange for about 25% ownership of Alvio. So It's not their proprietary product. It's Qol's proprietary product.
ADMT is just a shareholder in this situation.
That's a misstatement in their press release. It's misleading, actually fraudulent. They could get into big trouble with the SEC for fraudulently misleading the public into buying their stock. I've had this stock for years and at much higher prices. Hoping for something big to happen. Getting patents is no big deal. That means they are years away from bringing a product to market.
It's like the "Loop" they helped Assisihealth.com develop the 'Loop" now they make it for Assisi, when they get an order.
And "alvio" they said was still doing test production runs.
Not good
News 
Market Data 
Discover 
